Erlotinib is a Human Epidermal Growth Factor Receptor Type 1/Epidermal Growth Factor Receptor (HER1/EGFR) tyrosine kinase inhibitor. It is marketed as Tarceva for the treatment of locally advanced or metastatic non-small cell lung cancer or pancreatic cancer.
Related categories 1
Sites 2
Loading new listings for you to review...
- RxList: Tarceva (Erlotinib) Provides the medication description and drug information including side effects, interactions and patient labeling.
- Tarceva (Erlotinib) Advanced non-small cell lung cancer and advanced pancreatic cancer information. Official site from Genentech and OSI Pharmaceuticals.